Skip to content
Web Asset HouseAI Prescribing Watch
Menu

Informational only. Not affiliated with any government agency. Verify details at the official source.

Devices · Covidien, LLC

Instrument Exit Point on Touch Surgery™ Aide

510(k)K253984Gastroenterology-UrologySFE

Covidien, LLC is listed for Instrument Exit Point on Touch Surgery™ Aide (K253984). The FDA list gives June 4, 2026 as the date of the final decision. The lead panel is Gastroenterology-Urology, and the database link on the FDA list is the 510(k) pathway. openFDA describes product code SFE as “Endoscopic Video Imaging System / Software Component For Real Time Video Augmentation”: To allow for visualization of body cavities through an endoscope with real time augmentation of video images via software to a monitor. openFDA records this submission’s decision description as “Substantially Equivalent.” This paragraph is assembled only from those public fields. It is not an FDA review, not a determination of safety or effectiveness, and not medical advice. Official record: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMN/pmn.cfm?ID=K253984

Official FDA database record

Date of final decision
June 4, 2026
Company on the FDA list
Covidien, LLC
Lead panel
Gastroenterology-Urology
Primary product code
SFE
openFDA device name for the code
Endoscopic Video Imaging System / Software Component For Real Time Video Augmentation
Device class
2
Regulation number
876.1500
openFDA decision description
Substantially Equivalent
openFDA decision code
SESE
Statement or summary label
Summary

Product-code text from openFDA

To allow for visualization of body cavities through an endoscope with real time augmentation of video images via software to a monitor.

Other listings for this company